Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Interchangeable Insulins Could Be Left Out Of Diabetes Treatment ‘Ecosystem’
May 13 2019
•
By
Sue Sutter
Lilly wants the FDA to conduct a separate interchangeability assessment when insulin is used as part of a connected system. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Biosimilars
More from Biosimilars & Generics